Insmed Incorporated

The current price of INSM is $110.00 — it has increased by 5.32% since the previous close. Data as of Nov 4, 2026.

INSM is down 3.17% over the past week, down 1.01% over the past month and down 39.82% over the past year. The price is below its 200-day moving average of $124.88.

Analysts' average 12-month price target for INSM is $191.06, which implies 73.69% upside from the current price. Individual estimates range from $154.00 to $235.00.

Of the 24 analysts covering Insmed Incorporated, 5 rate it a strong buy, 18 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Insmed Incorporated has a market capitalization of $24.13B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Insmed Incorporated posted a loss of $0.46 per share against an estimate of -$0.3827, missing expectations by 20.19%. Upcoming reports are listed in the earnings calendar.

Insmed Incorporated reported revenue of $524.43M in its most recent quarter, which has increased by 268.43% compared with the same quarter a year earlier. Analysts had expected $500.36M.

Insmed Incorporated has not paid any dividends over the past year.

Companies most comparable to Insmed Incorporated include United Therapeutics Corporation, Liquidia Corporation, Avalyn Pharma Inc. Common Stock, Theravance Biopharma Inc and Pulmatrix, Inc.

In the latest trading session INSM moved between $102.82 and $110.81, a range of 7.27% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Insmed Incorporated shows a buy rating today and a sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Insmed Incorporated is neutral. Technical ratings are indicators, not investment advice.

Over the past 52 weeks INSM has traded between $90.39 and $212.75. The current price is 48.30% below its 52-week high.